Zinc Supplementation Modulates NETs Release and Neutrophils' Degranulation
In early clinical trials, patients on GLP-1 agonists have achieved weight loss of 1520%, compared to the 510% typically seen with previous medications. Holistic approach to GLP-1 drugs Beyond weight loss, GLP-1 agonists have demonstrated the ability to reduce major cardiovascular events, combat fatty liver disease and alleviate obesity-related complications such as knee pain, sleep apnea, and acid reflux
J Renin Angiotensin Aldosterone Syst
GHK-CU is itself a signal peptide, but with the added benefit of copper delivery
For Localized Treatment: Topical creams and laser treatments
For those dealing with harsh Canadian winters (which is most of us), barrier damage from cold, dry air makes peptides for barrier repair especially relevant